RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $791,000 | -86.1% | 700,000 | -63.2% | 0.00% | -81.8% |
| Q1 2022 | $5,681,000 | +2154.4% | 1,900,000 | +1900.0% | 0.01% | – |
| Q4 2021 | $252,000 | -78.4% | 95,000 | -84.2% | 0.00% | -100.0% |
| Q3 2014 | $1,164,000 | -46.6% | 600,000 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $2,178,000 | -43.9% | 600,000 | -40.0% | 0.01% | -45.5% |
| Q1 2014 | $3,880,000 | +256.9% | 1,000,000 | +525.5% | 0.01% | +175.0% |
| Q1 2013 | $1,087,000 | – | 159,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |